PD-L1 expression guidance on sintilimab vs. pembrolizumab with/without chemotherapy in untreated patients
A study published in the journal Science Bulletin was led by Yi-Long Wu (Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Chinese Thoracic Oncology Group (CTONG)).
Mar 5, 2024
0
0